Volume 77, Issue 2, Pages (January 2010)

Slides:

Advertisements

Similar presentations

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward Adeera Levin, Paul E. Stevens Kidney International

Advertisements

Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Membranous nephropathy: When and how to treat

Mycophenolate mofetil treatment for primary glomerular diseases

Reassessment of the care of the patient with chronic kidney disease

Volume 57, Issue 5, Pages (May 2000)

Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,

David J. Tunnicliffe, Suetonia C. Palmer

Volume 77, Issue 1, Pages 6-8 (January 2010)

Nat. Rev. Rheumatol. doi: /nrrheum

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials Suetonia C. Palmer,

Erratum American Journal of Kidney Diseases

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Pharmacokinetics of mycophenolic acid in severe lupus nephritis

Volume 77, Issue 1, Pages 5-6 (January 2010)

Volume 92, Issue 1, Pages (July 2017)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 77, Issue 2, Pages (January 2010)

Long-term study of mycophenolate mofetil treatment in IgA nephropathy

Volume 87, Issue 2, Pages (February 2015)

Volume 87, Issue 1, Pages (January 2015)

The calcium–phosphorus in guidelines for CKD-MBD

Volume 80, Issue 8, Pages (October 2011)

Nephrology Crossword: History of nephrology

Volume 73, Issue 10, Pages (May 2008)

Volume 84, Issue 4, Pages (October 2013)

Volume 76, Issue 6, Pages (September 2009)

Volume 87, Issue 1, Pages (January 2015)

A physician's perseverance uncovers problems in a key nephrology study

Günter Weiss, Florian Kronenberg Kidney International

Volume 82, Issue 10, Pages (November 2012)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Volume 93, Issue 1, Pages (January 2018)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Counteracting progression of renal disease: A look into the future

Volume 78, Issue 5, Pages (September 2010)

Nephrology Crossword: Glomerulonephritis

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Keng-Thye Woo, Yeow-Kok Lau, Kok-Seng Wong, Gilbert Shih-Chen Chiang

Volume 71, Issue 4, Pages (February 2007)

Current induction and maintenance treatment choices for proliferative lupus nephritis. Current induction and maintenance treatment choices for proliferative.

A man with a hole in his penis

Volume 82, Issue 9, Pages (November 2012)

The treatment of acute interstitial nephritis: More data at last

Volume 57, Issue 1, Pages (January 2000)

The course of the remnant kidney model in mice

Volume 65, Issue 5, Pages (May 2004)

Volume 80, Issue 10, Pages (November 2011)

Volume 83, Issue 4, Pages (April 2013)

ANCA-associated glomerulonephritis in the very elderly

Volume 86, Issue 2, Pages (August 2014)

Volume 62, Issue 2, Pages (August 2002)

Do meta-analyses in nephrology change the way we treat patients?

Dana V. Rizk, David G. Warnock Kidney International

The international realities of live donor kidney transplantation

Antioxidant therapy in hemodialysis patients: a systematic review

Increased fetuin-A levels following treatment with a vitamin D analog

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Current standard of care treatment protocols for LN induction therapy.

Presentation transcript:

Volume 77, Issue 2, Pages 152-160 (January 2010) Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis Jai Radhakrishnan, Dimitrios-Anestis Moutzouris, Ellen M. Ginzler, Neil Solomons, Ilias I. Siempos, Gerald B. Appel Kidney International Volume 77, Issue 2, Pages 152-160 (January 2010) DOI: 10.1038/ki.2009.412 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Weighted mean difference of percent change in proteinuria in patients randomized to MMF or IVC who completed 24 weeks of treatment. Kidney International 2010 77, 152-160DOI: (10.1038/ki.2009.412) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Weighted mean difference of percent change in serum creatinine in patients randomized to MMF or IVC who completed 24 weeks of treatment. Kidney International 2010 77, 152-160DOI: (10.1038/ki.2009.412) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Odds ratio for partial remission between the MMF group and IVC groups of patients who presented with nephrotic-range proteinuria. Kidney International 2010 77, 152-160DOI: (10.1038/ki.2009.412) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Weighted mean difference of percent change in proteinuria in patients who presented with nephrotic-range proteinuria, randomized to MMF or IVC, who completed 24 weeks of treatment. Kidney International 2010 77, 152-160DOI: (10.1038/ki.2009.412) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Enrollment of patients, treatment groups. Forty-two patients in each treatment group were included in the analysis of adverse effects. Only patients who completed the studies (65) were included in at least some of the efficacy analyses. Kidney International 2010 77, 152-160DOI: (10.1038/ki.2009.412) Copyright © 2010 International Society of Nephrology Terms and Conditions